In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria

被引：33
|
作者：
Zanetti, S [1 ]
Sechi, LA
Molicotti, P
Cannas, S
Bua, A
Deriu, A
Carta, A
Paglietti, G
机构：
[1] Sez Microbiol Sperimentale & Clin, Dipartimento Sci Biomed, Sassari, Italy
[2] Univ Sassari, Dipartimento Farmaco Chim Tossicol, Sassari, Italy
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2005年 / 25卷 / 02期
关键词：
D O I：
10.1016/j.ijantimicag.2004.11.003
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：179 / 181
页数：3
相关论文
共 50 条
  • [41] In Vitro Activity of the Triazinyl Diazepine Compound FTSD2 Against Drug-Resistant Mycobacterium tuberculosis Strains
    Aranaga, Carlos
    Varela, Ruben
    Falco, Aura
    Villa, Janny
    Moreno, Leydi M.
    Causse, Manuel
    Martinez-Martinez, Luis
    PHARMACEUTICALS, 2025, 18 (03)
  • [42] In vitro activity of (-)-deoxypergularinine, on its own and in combination with anti-tubercular drugs, against resistant strains of Mycobacterium tuberculosis
    Nam, Kung-Woo
    Jang, Woong Sik
    Jyoti, Md. Anirban
    Kim, Sukyung
    Lee, Byung-Eui
    Song, Ho-Yeon
    PHYTOMEDICINE, 2016, 23 (05) : 578 - 582
  • [43] Menthol- and thymol-based ciprofloxacin derivatives against Mycobacterium tuberculosis: in vitro activity, lipophilicity, and computational studies
    Szulczyk, Daniel
    Wozinski, Mateusz
    Kolinski, Michal
    Kmiecik, Sebastian
    Glogowska, Agnieszka
    Augustynowicz-Kopec, Ewa
    Dobrowolski, Michal A.
    Roszkowski, Piotr
    Struga, Marta
    Ciura, Krzesimir
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [44] Menthol- and thymol-based ciprofloxacin derivatives against Mycobacterium tuberculosis: in vitro activity, lipophilicity, and computational studies
    Daniel Szulczyk
    Mateusz Woziński
    Michał Koliński
    Sebastian Kmiecik
    Agnieszka Głogowska
    Ewa Augustynowicz-Kopeć
    Michał A. Dobrowolski
    Piotr Roszkowski
    Marta Struga
    Krzesimir Ciura
    Scientific Reports, 13
  • [45] Comparison of the in vitro antibacterial activity of ofloxacin, levofloxacin, moxifloxacin, sitafloxacin, finafloxacin, and delafloxacin against Mycobacterium tuberculosis strains isolated in China
    Kong, Yaoyao
    Geng, Zhi
    Jiang, Guanglu
    Jia, Junnan
    Wang, Fen
    Jiang, Xiaoyi
    Gu, Yuzhen
    Qi, Zhenyan
    Chu, Naihui
    Huang, Hairong
    Yu, Xia
    HELIYON, 2023, 9 (11)
  • [46] In vitro leishmanicidal activity of lactone 1,4-dihydroquinoline derivatives against Leishmania (Leishmania) amazonensis
    da Rocha Pissurno, Ana Paula
    Santos, Fernanda Amorim
    Bolela Bovo Candido, Ana Carolina
    Magalhaes, Lizandra Guidi
    de Laurentiz, Rosangela da Silva
    MEDICINAL CHEMISTRY RESEARCH, 2018, 27 (09) : 2224 - 2229
  • [47] In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis
    Fattorini, L
    Gennaro, R
    Zanetti, M
    Tan, DJ
    Brunori, L
    Giannoni, F
    Pardini, M
    Orefici, G
    PEPTIDES, 2004, 25 (07) : 1075 - 1077
  • [48] In vitro leishmanicidal activity of lactone 1,4-dihydroquinoline derivatives against Leishmania (Leishmania) amazonensis
    Ana Paula da Rocha Pissurno
    Fernanda Amorim Santos
    Ana Carolina Bolela Bovo Candido
    Lizandra Guidi Magalhães
    Rosangela da Silva de Laurentiz
    Medicinal Chemistry Research, 2018, 27 : 2224 - 2229
  • [49] Design of hybrid molecules as antimycobacterial compounds: Synthesis of isoniazid-naphthoquinone derivatives and their activity against susceptible and resistant strains of Mycobacterium tuberculosis
    Reis, Wallace J.
    Bozzi, Icaro A. O.
    Ribeiro, Matheus F.
    Halicki, Priscila C. B.
    Ferreira, Lais A.
    Almeida da Silva, Pedro E.
    Ramos, Daniela F.
    de Simone, Carlos A.
    da Silva Junior, Eufranio N.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2019, 27 (18) : 4143 - 4150
  • [50] Activities and conformational fitting of 1,4-naphthoquinone derivatives and other cyclic 1,4-diones tested in vitro against Pneumocystis carinii
    Ball, MD
    Bartlett, MS
    Shaw, M
    Smith, JW
    Nasr, M
    Meshnick, SR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (05) : 1473 - 1479
12345